White Bridge Investments completed the acquisition of a majority stake in Vida.

White Bridge Investments, a private equity firm, completed the acquisition of a majority stake in Vida, an injectable medical devices producer. Financial terms were not disclosed. "We were impressed by Vida Pharma's growth path in recent years and by the ability and dedication of its founder Dario Scaffai, who chose us as a partner to lead Vida Pharma to the next competitive level. Vida Pharma represents an excellent example of Italian business know-how in an extremely interesting and promising sector such as aesthetic medicine. We are proud and ready for the start of this new project, convinced that together we will achieve important goals," Marco Pinciroli, White Bridge President and CEO.